Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

New Prognostic and Predictive Biomarkers for HPV-associated Oropharyngeal Cancer

NCT06097936 is registered in ClinicalTrials.gov with Regina Elena Cancer Institute as lead sponsor.

NCT NCT06097936
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06097936 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
New Prognostic and Predictive Biomarkers for HPV-associated Oropharyngeal Cancer
Lead sponsor
Regina Elena Cancer Institute
Phase
Observational
Overall status
Unknown status
Start date
March 15, 2021
Completion date
April 1, 2024
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

evaluation of hpv-specific e5 transcript expression in a cohort of patients with hpv-associated opc, hpv 16 positive oropharyngeal tumors (opc), predictive biomarkers